Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,865Revenue $M6.5Net Margin (%)-3,700.1Altman Z-Score158
Enterprise Value $M8,154EPS $-5.9Operating Margin %-3,683.0Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.7Pre-tax Margin (%)-3,686.7Higher ROA y-yN
Price/Book12.010-y EBITDA Growth Rate %--Quick Ratio25.9Cash flow > EarningsY
Price/Sales1,3265-y EBITDA Growth Rate %--Current Ratio25.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-35.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-37.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M37.2ROIC % (ttm)-803.7Gross Margin Increase y-yN

Gurus Latest Trades with GEVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GEVAGeorge Soros 2013-12-31 Sold Out -0.01%$45.51 - $69.69
($59.17)
$ 238.60303%Sold Out0
GEVAGeorge Soros 2013-09-30 Buy 0.01%$43.26 - $62.55
($49.11)
$ 238.60386%New holding17,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GEVA is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GEVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Williams GlenSVP, Technical Operations 2015-06-08Sell12,916$214.9211.02 view
Williams GlenSVP, Technical Operations 2015-05-06Sell1,666$205.6216.04 view
Quinn AnthonyEVP, CMO & Head of R&D 2015-04-27Sell10,000$110116.91 view
Quinn AnthonyEVP, CMO & Head of R&D 2015-04-21Sell10,000$108120.93 view
Quinn AnthonyEVP, CMO & Head of R&D 2015-04-15Sell10,000$105127.24 view
Williams GlenSVP, Technical Operations 2015-04-08Sell42,632$96.08148.33 view
Quinn AnthonyEVP, CMO & Head of R&D 2015-04-06Sell29,503$93.76154.48 view
Heberlig ChrisSVP, Finance and Business Ops. 2015-03-11Sell7,500$103.17131.27 view
BOESS CARSTENSVP, CFO 2015-02-17Sell42,297$100.11138.34 view
BAKER FELIXDirector, 10% Owner 2015-01-07Buy1,000,000$94.19153.32 view

Quarterly/Annual Reports about GEVA:

News about GEVA:

Articles On GuruFocus.com
Alexion Acquiring Synageva For $8.4 Billion May 09 2015 
Wednesday Pre-Market Insights: GEVA, BRDR, MGI, NDLS, ZU May 06 2015 

More From Other Websites
ALEXION PHARMACEUTICALS, INC. Financials Jun 26 2015
SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Jun 23 2015
Alexion Completes Acquisition of Synageva Jun 23 2015
Alexion Accepts Shares of Synageva BioPharma Corp. Tendered Into Exchange Offer Jun 22 2015
GEVA helped advance Sectoral Asset 9.4% in May. ALXN did not Jun 17 2015
5 Healthy Stocks in the Top Biotech ETF - ETF News And Commentary Jun 17 2015
The Only Way to Play Biotech Buyouts Jun 09 2015
Synageva BioPharma Completes Targeted Enrollment in Phase 1/2 Trial with SBC-103 for... Jun 04 2015
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of... Jun 02 2015
Alexion and Synageva Announce Early Termination of Hart-Scott-Rodino Waiting Period for Alexion’s... May 29 2015
The Synageva BioPharma–Alexion Deal Spread Has Some Hair on It May 27 2015
Synageva BioPharma Files for Kanuma's Approval in Japan - Analyst Blog May 27 2015
Synageva BioPharma Submits Kanuma™ (Sebelipase Alfa) Application For LAL Deficiency In Japan May 26 2015
4 Big Biotech Companies to Sell Now May 26 2015
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of... May 22 2015
Pall-Danaher Transaction: What You Should Know about Danaher May 21 2015
Pall-Danaher Transaction: An Overview of Pall May 21 2015
Intercept's NASH Trial Design Irks Investors May 19 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synageva BioPharma Corp. of... May 18 2015
SYNAGEVA BIOPHARMA CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of... May 18 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK